title: The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model.
abstract: Allergic conjunctivitis (AC) is a common allergic eye disease characterized by clinical symptoms such as itchiness, conjunctival congestion, elevated Ag-specific IgE, mast cell activation, and local eosinophil infiltration. In this study we established a murine model for Ag-induced AC to understand the pathogenesis of the disease. Cell transfer experiments indicated that AC can be divided into early and late phase responses (EPR and LPR). EPR was associated with IgE responses, leading to itchiness, whereas LPR was characterized by local eosinophil infiltration. Both EPR and LPR were significantly inhibited in STAT6-deficient mice, and adoptive transfer of Th2 cells reconstituted LPR. Furthermore, SOCS3 was highly expressed at the disease site, and T cell-specific expression of SOCS3 deteriorated clinical and pathological features of AC, indicating that Th2-mediated SOCS3 expression controls the development and persistence of AC. Reduction of the expression level in SOCS3 heterozygous mice or inhibition of function in dominant-negative SOCS3 transgenic mice clearly reduced the severity of AC. In contrast, constitutive expression of SOCS5, a specific inhibitor of IL-4 signaling, resulted in reduced eosinophil infiltration. These results suggest that negative regulation of the Th2-mediated response by dominant-negative SOCS3 and SOCS5 could be a target for therapeutic intervention in allergic disease.
authors.affiliation: Laboratory for Signal Network, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, Kanagawa, Japan.
authors.forename: Akemi
authors.initials: A
authors.lastname: Ozaki
authors.forename: Yoh-ichi
authors.initials: Y
authors.lastname: Seki
authors.forename: Atsuki
authors.initials: A
authors.lastname: Fukushima
authors.forename: Masato
authors.initials: M
authors.lastname: Kubo
mesh_terms: D019264:Adoptive Transfer; D031164:Ambrosia / Q000276:immunology; D000818:Animals; D003228:Conjunctiva / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D003233:Conjunctivitis, Allergic / Q000276:immunology* / Q000378:metabolism* / Q000503:physiopathology; D004195:Disease Models, Animal; D004804:Eosinophils / Q000276:immunology; D007111:Immunity, Cellular / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011058:Pollen / Q000276:immunology; D012720:Severity of Illness Index; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins / Q000235:genetics / Q000502:physiology*; D018418:Th2 Cells / Q000276:immunology
chemical_list: C491411:Socs3 protein, mouse; C485811:Socs5 protein, mouse; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins